Vertex Pharmaceuticals, Inc’s filing revealed that its EVP, Chief Scientific Officer ALTSHULER DAVID unloaded Company’s shares for reported $0.53 million on Feb 20 ’25. In the deal valued at $480.00 per share,1,111 shares were sold. As a result of this transaction, ALTSHULER DAVID now holds 45,019 shares worth roughly $21.68 million.
Then, ALTSHULER DAVID bought 1,111 shares, generating $533,280 in total proceeds.
Before that, Tatsis Ourania sold 244 shares. Vertex Pharmaceuticals, Inc shares valued at $111,035 were divested by the EVP, Chief Reg. & Quality Off. at a price of $455.06 per share. As a result of the transaction, Tatsis Ourania now holds 67,695 shares, worth roughly $32.61 million.
Canaccord Genuity upgraded its Vertex Pharmaceuticals, Inc [VRTX] rating to a Hold from a a Sell in a research note published on February 12, 2025; the price target was increased to $424 from $408. A number of analysts have revised their coverage, including Canaccord Genuity’s analysts, who increased its forecast for the stock in mid February from “a Sell” to “a Hold”. Wells Fargo also remained covering VRTX and has decreased its forecast on January 30, 2025 with a “an Equal weight” recommendation from previously “an Overweight” rating. H.C. Wainwright maintained its rating on December 20, 2024. It rated VRTX as “a Buy”.
Price Performance Review of VRTX
On Friday, Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] saw its stock fall -0.53% to $481.65. Over the last five days, the stock has gained 4.93%. Vertex Pharmaceuticals, Inc shares have risen nearly 19.61% since the year began. Nevertheless, the stocks have risen 14.78% over the past one year. While a 52-week high of $519.88 was reached on 02/05/25, a 52-week low of $377.85 was recorded on 01/13/25. SMA at 50 days reached $440.91, while 200 days put it at $464.50.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 477.97, which if violated will result in even more drops to 474.28. On the upside, there is a resistance level at 486.42. A further resistance level may holdings at 491.18. The Relative Strength Index (RSI) on the 14-day chart is 63.68, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 10.55, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 22.17%. Stochastics %K at 78.75% indicates the stock is a holding.
